Kiplinger Letter, The - Relief is in sight on Rx drug costs.(HEALTH COSTS)(Brief Article)
Relief is in sight on Rx drug costs: A pillbox of new generics is coming. Antidepressants Celexa, Zoloft and Wellbutrin, ulcer-fighters Prevacid and Aciphex and cholesterol-lowering Pravachol and Zocor will all lose patent protection over the next three years.
Related Results
Eisai bolsters its sales team to promote CNS products, increase independence
Eisai, Janssen educate consumers on acid reflux
Japan Drug Firm Eisai Posts Increased Sales, Profits for Fiscal First Half.
Prevacid held slight lead in proton pump inhibitor sales to retailers for 200…
“Ac”cident potential
Health plans will aggressively push use of the cheaper generics, coupling educational efforts with changes in …
Read the rest of this article with a Free Trial at HighBeam Research.
